Christin Chong, PhD

Reframe Daily: Tiny microrobots could revolutionize cancer treatment in the gut

Mar 13, 2026

•

3 min read

Reframe Daily: Tiny microrobots could revolutionize cancer treatment in the gut

New technology aims for precise cancer targeting with fewer side effects.

Christin Chong, PhD

Reframe Daily: New vaccine shows promise against deadly Nipah virus in initial trial

Mar 12, 2026

•

3 min read

Reframe Daily: New vaccine shows promise against deadly Nipah virus in initial trial

Scientists develop a safe mRNA vaccine to protect against a serious illness.

Christin Chong, PhD

Reframe Daily: New strategy to fight coronaviruses targets our own cells, new FDA adverse events tool

Mar 11, 2026

•

3 min read

Reframe Daily: New strategy to fight coronaviruses targets our own cells, new FDA adverse events tool

Plus: Discover how amino acids can boost future mRNA medicines for better health.

Christin Chong, PhD

Reframe Daily: FDA clears the first treatment for cerebral folate transport deficiency

Mar 10, 2026

•

4 min read

Reframe Daily: FDA clears the first treatment for cerebral folate transport deficiency

Plus: a new phase 3 lung-cancer combo that beats pembrolizumab on keeping disease in check.

Christin Chong, PhD

Reframe Daily: A ventilator strategy many NICUs already have may better protect newborn lungs

Mar 9, 2026

•

4 min read

Reframe Daily: A ventilator strategy many NICUs already have may better protect newborn lungs

Plus: VR vision therapy shows promise for kids with wandering eyes—and flu shots’ antibody boost against a newer H3N2 strain.

Christin Chong, PhD

Reframe Daily: FDA clears Tec-Dara combo for relapsed multiple myeloma

Mar 6, 2026

•

4 min read

Reframe Daily: FDA clears Tec-Dara combo for relapsed multiple myeloma

Plus: a CT-reading AI trained on real reports, and new clues to stop breast cancer drug resistance.

Christin Chong, PhD

Reframe Daily: New combination therapy offers fresh hope for multiple myeloma patients

Mar 5, 2026

•

3 min read

Reframe Daily: New combination therapy offers fresh hope for multiple myeloma patients

Plus: exciting early research into stroke prevention, better diagnostics, and how diet influences fat-burning cells.

Christin Chong, PhD

Reframe Daily: Leukemia patients can stop meds and still stay well—without daily pills

Mar 4, 2026

•

3 min read

Reframe Daily: Leukemia patients can stop meds and still stay well—without daily pills

Plus: turning CAR T on only in low‐oxygen zones and timing immunotherapy by time of day could make treatments safer and stronger.

Christin Chong, PhD

Reframe Daily: Catheter ablation plus blood thinner cuts repeat strokes in atrial fibrillation

Mar 3, 2026

•

3 min read

Reframe Daily: Catheter ablation plus blood thinner cuts repeat strokes in atrial fibrillation

A new study shows combining two existing tools helps prevent repeat strokes—plus, early news on low‐dose lithium for memory problems and a promising diabetes therapy.

Christin Chong, PhD

Reframe Daily: Home sleep test nails severe sleep apnea, plus a tiny skin patch that checks your immune cells

Mar 2, 2026

•

3 min read

Reframe Daily: Home sleep test nails severe sleep apnea, plus a tiny skin patch that checks your immune cells

A home sleep test in regular clinics can spot severe sleep apnea well; NICUs may cut dangerous brain bleeding in tiny preemies; gentle brain stimulation shifts anxious thinking; a microneedle patch samples immune cells from skin; and a new one-two flu shot plan broadened protection in animals.

Christin Chong, PhD

Reframe Daily: news and a mini app for you to stay healthy

Feb 27, 2026

•

3 min read

Reframe Daily: news and a mini app for you to stay healthy

One study tested a vancomycin step-down plan to stop C. diff from coming back, another sped up feeding-tube placement in ICU patients, HIV clinics boosted quit rates with meds plus small rewards, a new inherited-high-cholesterol pill dropped LDL, and a new GLP-1 shot every 2 weeks drove weight loss in a phase 2b trial.

Christin Chong, PhD

Reframe Daily: HIV monthly shots worked for people who struggle with daily pills

Feb 26, 2026

•

3 min read

Reframe Daily: HIV monthly shots worked for people who struggle with daily pills

Plus: a glaucoma coaching program boosted eye-drop use, and the FDA cleared a new lung cancer drug faster with its voucher pilot

Christin Chong, PhD

Reframe Daily: Radiation shot beat seed therapy for prostate cancer, plus a smarter brain implant and a gut-to-brain TBI clue

Feb 25, 2026

•

3 min read

Reframe Daily: Radiation shot beat seed therapy for prostate cancer, plus a smarter brain implant and a gut-to-brain TBI clue

A JAMA study says SBRT caused fewer early bladder/urine problems than HDR brachytherapy; a Parkinson’s brain implant can better “self-tune” over time; antibiotics reshaped gut bugs and lowered brain inflammation after TBI in lab work; scientists mapped how toxic alpha-synuclein may spread in Parkinson’s; and a blood-cell mutation link may explain why some aortic aneurysms grow.

Christin Chong, PhD

Reframe Daily: ER pain relief now: morphine + Tylenol helped in a randomized trial

Feb 24, 2026

•

3 min read

Reframe Daily: ER pain relief now: morphine + Tylenol helped in a randomized trial

A randomized ER trial found morphine plus acetaminophen eased acute pain better in the first hour; a case report suggests sotatercept could help a tough liver-linked lung blood-pressure condition; scientists built heat-stable polio virus-like particles that still trigger strong antibodies; a Nature study mapped how some HIV reservoir cells dodge killer T cells; and researchers showed birth control hormones can shift EEG signals used to predict antidepressant response in women.

Christin Chong, PhD

Reframe Daily: Breast ultrasound finds more serious cancers early, plus a stroke drug helps up to 24 hours later

Feb 23, 2026

•

3 min read

Reframe Daily: Breast ultrasound finds more serious cancers early, plus a stroke drug helps up to 24 hours later

A study found that adding breast ultrasound can catch more advanced cancers sooner, a clot-busting drug helped some people recover after a dangerous stroke even when given late, an intense workout plan improved blood fats and inflammation in 8 weeks, thalassemia patients got safer transplant options, and a new anti-reflux stent reduced pain after stone surgery.

Christin Chong, PhD

Reframe Daily: New “Flying Needle” blood draw hurt less, and a fasting-mimic pill cut hunger in a human trial

Feb 20, 2026

•

4 min read

Reframe Daily: New “Flying Needle” blood draw hurt less, and a fasting-mimic pill cut hunger in a human trial

A painless blood-draw tool worked in a randomized study, a fasting-mimic supplement improved cholesterol and blood sugar, a faster TMS-style depression treatment helped mood and social function, a live biotherapy lowered deaths in tiny preterm babies, and a new Parkinson’s pill looked safe in an early trial.

Christin Chong, PhD

Reframe Daily: gentler brain radiation, a one-time gene fix, and a new myotonic dystrophy study

Feb 19, 2026

•

3 min read

Reframe Daily: gentler brain radiation, a one-time gene fix, and a new myotonic dystrophy study

A JAMA trial found a targeted brain radiation plan eased daily-life symptoms; NEJM reported a one-time stem-cell gene therapy for cystinosis and a new antibody-linked RNA blocker for myotonic dystrophy; plus a next-gen COVID shot and an immune “T-cell engager” approach for tough autoimmune disease.

Christin Chong, PhD

Reframe Daily: Tear drops may spot Parkinson’s early, and a short mindfulness program eased gaming addiction

Feb 18, 2026

•

3 min read

Reframe Daily: Tear drops may spot Parkinson’s early, and a short mindfulness program eased gaming addiction

A study found a Parkinson’s disease signal in tear fluid; a short mindfulness program lowered gaming cravings and depression; researchers found a kidney-protecting “switch” (RORγ) linked to diabetes and aging; scientists pinned down a new fatty liver disease (MASH) driver (RYK tied to GPNMB) they could block in lab models; and sulforaphane delivered in exosomes helped sperm recover in rats. The FDA posted no press announcements today.

Christin Chong, PhD

Reframe Daily: 5-year MS drug results, tumor-injected virus for breast cancer, new gene therapy for melanoma, ultrasound memory boost, bee-sting allergy blocker

Feb 17, 2026

•

3 min read

Reframe Daily: 5-year MS drug results, tumor-injected virus for breast cancer, new gene therapy for melanoma, ultrasound memory boost, bee-sting allergy blocker

A 5-year study suggests the MS drug ublituximab can keep relapses low; a tumor-injected virus plus an immune drug helped some people have much less breast cancer at surgery; a gene-therapy approach plus an immune drug slowed melanoma in some patients after earlier treatments failed; focused ultrasound brain stimulation improved word-meaning memory tests; and a new antibody “blocker” cut the main honeybee-venom allergen in early lab and mouse work.

Christin Chong, PhD

Reframe Daily: Mustard + broccoli doubled a helpful nutrient, DMT eased depression

Feb 16, 2026

•

3 min read

Reframe Daily: Mustard + broccoli doubled a helpful nutrient, DMT eased depression

A probiotic lowered a kidney toxin, a short DMT IV eased depression in an early trial, and new COVID antivirals worked in mice.

Christin Chong, PhD

Reframe Daily: Stroke rehab gear that “talks” to the brain, plus a near-painless glucose microneedle sensor

Feb 13, 2026

•

3 min read

Reframe Daily: Stroke rehab gear that “talks” to the brain, plus a near-painless glucose microneedle sensor

New studies today tested a brain-to-robot exoskeleton to help stroke arms move again, a tiny graphene microneedle sensor for glucose tracking, a rhubarb-based way to restart gut motion in pancreatitis, antibody-carrying exosomes for bowel disease, and “armored” probiotics that survive stomach acid to fight colitis.

Christin Chong, PhD

Reframe Daily: Vaccine trial blocks hand-foot-and-mouth virus in kids, plus FDA clears a new pancreatic cancer device

Feb 12, 2026

•

4 min read

Reframe Daily: Vaccine trial blocks hand-foot-and-mouth virus in kids, plus FDA clears a new pancreatic cancer device

A Phase 3 vaccine stopped most EV-A71 cases; an IVF lab “chip” rescued usable eggs; a new immune drug may cut repeat UTIs without antibiotics; PD-1 cancer therapy in people with HIV linked to a drop in hidden virus; a new antibody targets metapneumovirus; and FDA both approved a first-of-its-kind pancreatic cancer device and updated menopause hormone therapy labels.

Christin Chong, PhD

Reframe Daily: ER addiction shot works fast, plus new Alzheimer’s gene drug and a heart-rhythm reset tool

Feb 11, 2026

•

3 min read

Reframe Daily: ER addiction shot works fast, plus new Alzheimer’s gene drug and a heart-rhythm reset tool

A weekly buprenorphine shot in the ER matched the usual pill in an RCT, a handheld “Valsalva” device stopped SVT more often, BIIB080 showed early Alzheimer’s promise, astaxanthin helped PCOS egg maturity in IVF, and cholesterol-targeting eased lymphedema in mice.

Christin Chong, PhD

Reframe Daily: Ear-nerve stimulation + balance rehab cut vestibular-migraine dizziness (plus a new dengue drug idea)

Feb 10, 2026

•

4 min read

Reframe Daily: Ear-nerve stimulation + balance rehab cut vestibular-migraine dizziness (plus a new dengue drug idea)

One trial found ear-nerve stimulation added to balance therapy eased dizziness and improved steadiness; researchers also reported a KRAS cancer vaccine early signal, a nano-ultrasound TB approach, a new dengue “protein-degrader” drug concept, a chemo swap with fewer side effects, and the FDA began a fresh safety review of the preservative BHA.

Christin Chong, PhD

Reframe Daily: C-section moms felt less anxious with help and preterm babies had less body fat in new trials

Feb 9, 2026

•

4 min read

Reframe Daily: C-section moms felt less anxious with help and preterm babies had less body fat in new trials

A strength-training program helped people with CLL get stronger and sleep better, a probiotic lowered LDL in some adults, and a gene-edited pig liver kept working to support human liver function outside the body.

Christin Chong, PhD